prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, FINAL DIAGNOSIS: PART 1: BREAST,RIGHT, SEGMENTAL MASTECTOMY, NEEDLE LOCALIZATION -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 3 (TUBULE FORMATION 3, NUCLEAR. POLYMORPHISM 3, MITOTIC ACTIVITY 3, TOTAL SCORE 9/9). B. INVASIVE TUMOR MEASURES 2.1 CM IN GREATEST DIMENSION (GROSS MEASUREMENT). C. DUCTAL CARCINOMA IN SITU (DCIS), SOLID PATTERN, NUCLEAR GRADE 3, ADMIXED WITH INVASIVE. CARCINOMA, CONSTITUTING ABOUT FIVE PERCENT (5%) OF TOTAL TUMOR VOLUME. D. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA; INVASIVE CARCINOMA IS 1.5 MM TO THE. CLOSEST ANTERIOR MARGIN. E. NO DEFINITIVE LYMPHOVASCULAR INVASION NOTED. F. FOCI OF MICROCALCIFICATIONS ASSOCIATED WITH INVASIVE CARCINOMA. G. FIBROCYSTIC CHANGE. H. THE INVASIVE CARCINOMA IS ER POSITIVE, PR POSITIVE, HER2/NEU WEAKLY POSITIVE AND NO. AMPLIFICATION BY FISH ANALYSIS. PART 2: AXILLA #1 SENTINEL LYMPH NODE, RIGHT, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. SYNOPTIC - PRIMARI INVASIVE ,. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2.1 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Solid. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 1.5 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES EXAMINED: 1. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.

expanded version (tokens=1101) : 
 The breast pathology report includes the following information:

- Histological classification: The subtype is Luminal A. The diagnosis includes invasive ductal carcinoma, with features of Nottingham grade 3 and ductal carcinoma in situ (DCIS) of solid pattern, nuclear grade 3.

- Necrosis: There is no mention of necrosis in the report.

- Tumor infiltrating lymphocytes: There is no mention of tumor infiltrating lymphocytes in the report.

- Histological grade: The Nottingham histological grade is 3/3, with tubule formation score of 3, nuclear polymorphism score of 3, and mitotic activity score of 3.

- Nuclear grade: The nuclear grade for both invasive ductal carcinoma and DCIS is 3.

- Lymphovascular invasion: No definitive lymphovascular invasion is noted in the report.

- Calcification: Foci of microcalcifications are associated with invasive carcinoma.

- Receptor status: The invasive carcinoma is ER-positive, PR-positive, and HER2/NEU weakly positive with no amplification by FISH analysis.

- IHC: The hormone receptors (ER, PR) are positive. HER2/NEU is weakly positive.

- Ancillary testing results: There is no mention of any other ancillary testing results in the report.

Additional details from the report include the size of the invasive tumor (2.1 cm), the percentage of tumor volume that is DCIS (about 5%),

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1267) : 
 This is a Luminal A subtype breast cancer with invasive ductal carcinoma, grade 3 of Nottingham histological classification, measuring 2.1 cm in greatest dimension with no lymphovascular invasion noted. The tumor is estrogen and progesterone receptor positive, HER2/NEU weakly positive without amplification by FISH analysis. Five percent of the total tumor volume constitutes ductal carcinoma in situ (DCIS) of the solid pattern with nuclear grade 3 admixed with invasive carcinoma. Surgical margins are negative for carcinoma, and one lymph node is negative for metastatic carcinoma.

